Community Health (CYH) Q4 Earnings Beat on Strong Admissions
Community Health Systems, Inc. CYH reported fourth-quarter 2022 adjusted net earnings of $1.50 per share, which surpassed the Zacks Consensus Estimate of 41 cents per share. Additionally, the bottom line climbed 30.4% year over year.
Net operating revenues slid 2.8% year over year to $3,142 million in the quarter under review. Also, the top line fell shy of the consensus mark of $3,170 million and our estimate of $3,142.5 million.
The quarterly results benefited on the back of improved admissions and adjusted admissions. An increase in the count of surgeries also contributed to the quarterly results. However, the upside was partly offset by an elevated expense level.
Community Health Systems, Inc. Price, Consensus and EPS Surprise
Community Health Systems, Inc. price-consensus-eps-surprise-chart | Community Health Systems, Inc. Quote
Quarterly Operational Update
At the fourth-quarter end, the hospital count for Community Health stood at 80, which lagged both the Zacks Consensus Estimate and our estimate of 81.
Patient days tumbled 7.5% year over year. The average length of stay fell 9.8% year over year, while the occupancy rate of 50% deteriorated 150 basis points year over year.
Admissions grew 1.9% year over year. Meanwhile, adjusted admissions advanced 5.2% year over year in the quarter under review. On a same-store basis, admissions and adjusted admissions improved 4.4% and 8.2%, respectively, from their corresponding prior-year quarter’s reported figures.
Licensed beds of CYH totaled 12,832 as of Dec 31, 2022, which indicates a decrease of 457 beds from the 2021-end level. The reported figure missed both the consensus mark and our estimate of 13,333.
Total operating costs and expenses increased 3.7% year over year to $2,914 million in the fourth quarter, lower than our estimate of $2,968.7 million. The increase was mainly due to higher salaries and benefits and other operating expenses. Meanwhile, net interest expenses of $205 million declined 6.8% year over year.
Community Health reported a net income of $446 million, which doubled year over year. Adjusted EBITDA dropped 25.2% year over year to $404 million in the quarter under review primarily due to reduced acuity of inpatient admissions, unfavorable changes in payor mix and lower pandemic relief funds recognized.
Financial Update (as of Dec 31, 2022)
Community Health exited the fourth quarter with cash and cash equivalents of $118 million, which declined more than four-fold from the figure in 2021 end. Total assets of $14,669 million fell 3.6% from the 2021-end level.
Long-term debt amounted to $11,614 million, which decreased 4.1% from the figure as of Dec 31, 2021. Current maturities of long-term debt came in at $21 million.
During 2022, CYH generated operating cash flows of $300 million. Net cash used in operating activities came in at $131 million in 2021.
Net operating revenues are anticipated to lie between $12,200 million and $12,600 million this year, the mid-point of which indicates a rise of 1.5% from the 2022 reported figure of $12,211 million.
Adjusted EBITDA is estimated to lie within $1,475-$1,625 million. The mid-point of the guidance implies a 5.7% rise from the 2022 figure of $1,466 million.
Net loss per share is forecasted to lie between 65 cents and 5 cents in 2023. Community Health reported a net loss of $1.38 per share in 2022.
Depreciation and amortization are predicted within $510-$530 million. Net interest expense is estimated to lie in the $815-$835 million band.
Net cash provided by operating activities is anticipated between $675 million and $825 million in 2023. Capital expenditures are expected within $450-$500 million. Diluted weighted-average shares outstanding is estimated within 130-131 million.
Community Health currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other Medical Sector Releases
Of the other Medical sector players that have reported fourth-quarter results so far, the bottom lines of DexCom, Inc. DXCM, Tenet Healthcare Corporation THC and Ecolab Inc. ECL beat the Zacks Consensus Estimate.
DexCom reported fourth-quarter 2022 adjusted earnings per share of 34 cents, beating the Zacks Consensus Estimate of 26 cents by 30.8%. The company had recorded an adjusted loss of 1 cent per share in the prior-year quarter. Total revenues grew 17% (20% on an organic basis) to $815.2 million on a year-over-year basis and beat the Zacks Consensus Estimate by 2.2%. The gross profit of DXCM totaled $541.3 million, up 14.5% year over year. It generated a gross margin (as a percentage of revenues) of 66.4%, which contracted 130 basis points (bps) year over year.
Tenet Healthcare’s fourth-quarter 2022 adjusted earnings of $1.96 per share surpassed the Zacks Consensus Estimate by 54.3%. However, the bottom line dropped 27.4% year over year. Net operating revenues improved 2.6% year over year to $4,990 million in the quarter under review. The top line beat the consensus mark by 1.7%. Adjusted net income from continuing operations of THC of $213 million slid 27.5% year over year. Adjusted EBITDA dipped 11.8% year over year to $897 million.
Ecolab reported fourth-quarter 2022 adjusted earnings per share of $1.27, down year over year by a penny. The bottom line, however, beat the Zacks Consensus Estimate by 1.6%. Revenues grossed $3.67 billion in the reported quarter, up 9.1% year over year. The metric surpassed the Zacks Consensus Estimate by 0.04%. ECL’s fixed-currency sales increased 15.3%, and acquisition-adjusted fixed-currency sales increased 12% from the prior-year period’s level.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ecolab Inc. (ECL) : Free Stock Analysis Report
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
DexCom, Inc. (DXCM) : Free Stock Analysis Report
Community Health Systems, Inc. (CYH) : Free Stock Analysis Report
To read this article on Zacks.com click here.